FDA Approves Actemera for Earlier Stages of RA

The FDA has widened the approved use of rheumatoid arthritis drug Actemera to include patients who are in earlier stages of treatment for the disease. Previously, Actemera was approved for patients who were not helped by use of TNF inhibitors (such as Humira and Embrel).

To learn more, click here.